WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mayukh SukhatmePres;CIO2026-08-21144,756$3.85
$557.31kBuy
Mayukh SukhatmePres;CIO2026-08-21144,756$36.48
$5.28MSell
Mayukh SukhatmePres;CIO2026-08-2017,519$37.30
$653.46kSell
Mayukh SukhatmePres;CIO2026-08-2017,519$3.85
$67.45kBuy
Mayukh SukhatmePres;CIO2026-08-19172,899$37.17
$6.43MSell
Mayukh SukhatmePres;CIO2026-08-19172,899$3.85
$665.66kBuy
Mayukh SukhatmePres;CIO2026-08-1831,801$3.85
$122.43kBuy
Mayukh SukhatmePres;CIO2026-08-1831,801$37.18
$1.18MSell
Mayukh SukhatmePres;CIO2026-08-18105,141$3.85
$404.79kBuy
Mayukh SukhatmePres;CIO2026-08-18105,141$36.59
$3.85MSell

1 of 22

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Qvt Financial LP15.76%113,830,063$4.13BInsider
Daniel Allen Gold14.80%106,895,473$3.88BInsider
Dexcel Pharma Technologies Ltd14.24%102,849,443$3.73BInsider
Svf Investments Uk Ltd10.11%73,031,667$2.65BInsider
Keith S. Manchester9.90%71,529,411$2.60BInsider
Sumitomo Chemical Co Ltd9.86%71,251,083$2.59BInsider
Vivek Ramaswamy6.51%47,011,612$1.71BInsider
Mayukh Sukhatme2.81%20,288,437$736.47MInsider
Matthew Gline2.31%16,659,945$604.76MInsider
Frank Torti1.87%13,536,202$491.36MInsider

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV0.08%92.25%Net SellingNet Selling
INCY0.10%28.09%Net SellingNet Selling
INSM0.10%17.37%Net SellingNet Selling
BNTX0.02%16.46%Net Selling
UTHR0.10%14.82%Net SellingNet Buying
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 0.08% institutional shareholders, 92.25% Roivant Sciences insiders, and 7.68% retail investors. Qvt Financial LP is the largest individual Roivant Sciences shareholder, owning 113.83M shares representing 15.76% of the company. Qvt Financial LP's Roivant Sciences shares are currently valued at $4.13B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.